Stock Ratings / Health Care / MDGL / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Madrigal Pharmaceuticals Inc. (MDGL) 12-Month Stock Forecast & Price Target Cone

$431.70 +0.16% NASDAQ • Public Delayed / 60s Snapshot

Madrigal Pharmaceuticals Inc. (MDGL) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C- • HOLD / WATCH Cap $9.97B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+0.9% Base Target

WHALE OPTIONS TUG-OF-WAR:56% Call Buyers ($2.5M)

44% PutsMax Pain: $423.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your MDGL Position Size: $10,000

Shares at $431.70: 23.2 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $339.76

$7,870

$-2,130 (-21.3%)

12M Consensus BaseTarget $435.59

$10,090

+$90 (+0.9%)

12M Bull Case BreakoutTarget $645.75

$14,958

+$4,958 (+49.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$453	74%	A
Goldman SachsSector Coverage Lead	BUY	$607	69%	B
JP MorganUS Large-Cap Research	HOLD	$388	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live MDGL Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

MDGL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -16.82%▼ DESCENDING CHANNEL

2026-10-30O $431.6H $437.8L $425.0C $430.4VOL 251.6K

RES: $531.9SUP: $395.1SMA50: $498.7SMA200: $500.0

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MDGL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MDGL Butterfly Map → + Track MDGL →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

17.8%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MDGL today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MDGL. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MDGL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

MDGL Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is MDGL's 12-month stock price target?

Madrigal Pharmaceuticals Inc. (MDGL) carries a 12-month consensus base price target of $435.59 (+0.9% from $431.70), with a bull-case target of $645.75 and a bear-case floor of $339.76.

Is MDGL stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates MDGL C- (Hold — HOLD) with an RQD Confidence score of 60/100.

Direct Sub-Reports: MDGL RQD Cockpit MDGL 12M Forecast MDGL Earnings & Move MDGL Dividends & DRIP MDGL Insiders & 13F MDGL Whale Options MDGL Profit Sankey MDGL News & Why